Part of GC Biopharma, delivering safe and effective therapies to patients worldwide.
Bringing our extensive plasma technology, knowledge and expertise to the US.
Our past success is the foundation of our future.
GC Biopharma Initiates Voluntary Market Withdrawal of One Lot of Product
GC Biopharma Supports New Insights into Education, Safety, and Patient Outcomes in Ig Therapy Care at the 2025 IgNS Annual Meeting
GC Biopharma Announces Symposium on Clinical and Patient Experience in Primary Immunodeficiency at the 2025 IgNS Annual Meeting
GC Biopharma Highlights IVIG Innovation and Investigator-Initiated Research as Science to Solutions Partner at the Fall 2025 CIIC Conference
GC Biopharma Announces Publication Demonstrating 14-Day Stability of Pooled ALYGLO® Under Refrigerated Conditions
GC Biopharma Launches ALYGLO® - Now Available in the US Marketplace...
GC Biopharma USA Announces US FDA Approval for ALYGLO®
Learn more about our CEX Chromatography manufacturing process
Check out our interactive timeline here.
- GC Labtech (Plasma Testing Lab, San Antonio, TX)
- Curevo Vaccine (Seattle)
- Artiva (SanDiego)
- GC Biopharma
- GCMS
- GC Wellbeing
- GC Cell
- GC Labcell
- GC Labs
- GC Genome
- GC Healthcare
- GC i-Med
- Mogam Institute for Biomedical Research
- GCEM
- GC China (Plasma Manufacturing)
- GC ChinaPharm (Marketing & Sales)
